Matches in SemOpenAlex for { <https://semopenalex.org/work/W4235283202> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4235283202 endingPage "vi203" @default.
- W4235283202 startingPage "vi203" @default.
- W4235283202 abstract "When glioma patients experience long-term seizure freedom the question arises whether antiepileptic drugs (AEDs) should be continued. We performed a prospective study on the decision-making process to withdraw AEDs in glioma patients with long-term seizure freedom, and on seizure outcome after withdrawal. Patients with a histologically confirmed low grade or anaplastic glioma were included. Patients eligible for the study were seizure free for ≥ 1 year counted from the date of last surgery, irradiation or chemotherapy, or ≥ 2 years since the last seizure after antitumor treatment. Primary outcome measures were: 1) the outcome of the shared-decision making process (i.e. AED withdrawal or continuation) and 2) the rate of successful AED withdrawal. Between January 2014 and December 2016, 83 patients fulfilled all eligibility criteria. In 12/83 (14%) of patients, the neuro-oncologist had serious objections to AED withdrawal. Therefore, 71/83 (86%) were included in the study. In 46/71 (65%) patients AEDs were withdrawn and in 25/71 (35%) AEDs were continued. Median follow-up was 2.0 years (range 0.8-3.8). Twenty-six percent (12/46) had seizure recurrence during-follow up; six of these twelve patients (50%) had tumor progression, of which three patients had tumor progression within three months after seizure recurrence. Median time of tumor progression after seizure recurrence is 8.5 months (range: 0.2-19 months). Eight patients had a focal seizure, three patients a generalized seizure and one patient had a complex-partial status epilepticus. In the AED continuation group, none of the patients had seizure recurrence. In this group one patient had tumor progression. Sixty-five percent of selected patients preferred to withdraw their AEDs, of which 26% had seizure recurrence. AED withdrawal should only be considered in carefully selected patients." @default.
- W4235283202 created "2022-05-12" @default.
- W4235283202 creator A5004901028 @default.
- W4235283202 creator A5015612720 @default.
- W4235283202 creator A5018569017 @default.
- W4235283202 creator A5026126995 @default.
- W4235283202 creator A5027431274 @default.
- W4235283202 creator A5037395192 @default.
- W4235283202 creator A5056837393 @default.
- W4235283202 creator A5066947589 @default.
- W4235283202 creator A5074907870 @default.
- W4235283202 creator A5085953690 @default.
- W4235283202 creator A5086283695 @default.
- W4235283202 date "2017-11-01" @default.
- W4235283202 modified "2023-10-16" @default.
- W4235283202 title "QLIF-11. WITHDRAWAL OF ANTIEPILEPTIC DRUGS IN GLIOMA PATIENTS AFTER LONG-TERM SEIZURE FREEDOM" @default.
- W4235283202 doi "https://doi.org/10.1093/neuonc/nox168.821" @default.
- W4235283202 hasPublicationYear "2017" @default.
- W4235283202 type Work @default.
- W4235283202 citedByCount "0" @default.
- W4235283202 crossrefType "journal-article" @default.
- W4235283202 hasAuthorship W4235283202A5004901028 @default.
- W4235283202 hasAuthorship W4235283202A5015612720 @default.
- W4235283202 hasAuthorship W4235283202A5018569017 @default.
- W4235283202 hasAuthorship W4235283202A5026126995 @default.
- W4235283202 hasAuthorship W4235283202A5027431274 @default.
- W4235283202 hasAuthorship W4235283202A5037395192 @default.
- W4235283202 hasAuthorship W4235283202A5056837393 @default.
- W4235283202 hasAuthorship W4235283202A5066947589 @default.
- W4235283202 hasAuthorship W4235283202A5074907870 @default.
- W4235283202 hasAuthorship W4235283202A5085953690 @default.
- W4235283202 hasAuthorship W4235283202A5086283695 @default.
- W4235283202 hasBestOaLocation W42352832021 @default.
- W4235283202 hasConcept C118552586 @default.
- W4235283202 hasConcept C141071460 @default.
- W4235283202 hasConcept C187212893 @default.
- W4235283202 hasConcept C2776694085 @default.
- W4235283202 hasConcept C2777341932 @default.
- W4235283202 hasConcept C2778186239 @default.
- W4235283202 hasConcept C2778227246 @default.
- W4235283202 hasConcept C2779130545 @default.
- W4235283202 hasConcept C42219234 @default.
- W4235283202 hasConcept C502942594 @default.
- W4235283202 hasConcept C71924100 @default.
- W4235283202 hasConceptScore W4235283202C118552586 @default.
- W4235283202 hasConceptScore W4235283202C141071460 @default.
- W4235283202 hasConceptScore W4235283202C187212893 @default.
- W4235283202 hasConceptScore W4235283202C2776694085 @default.
- W4235283202 hasConceptScore W4235283202C2777341932 @default.
- W4235283202 hasConceptScore W4235283202C2778186239 @default.
- W4235283202 hasConceptScore W4235283202C2778227246 @default.
- W4235283202 hasConceptScore W4235283202C2779130545 @default.
- W4235283202 hasConceptScore W4235283202C42219234 @default.
- W4235283202 hasConceptScore W4235283202C502942594 @default.
- W4235283202 hasConceptScore W4235283202C71924100 @default.
- W4235283202 hasIssue "suppl_6" @default.
- W4235283202 hasLocation W42352832021 @default.
- W4235283202 hasLocation W42352832022 @default.
- W4235283202 hasLocation W42352832023 @default.
- W4235283202 hasOpenAccess W4235283202 @default.
- W4235283202 hasPrimaryLocation W42352832021 @default.
- W4235283202 hasRelatedWork W1765205796 @default.
- W4235283202 hasRelatedWork W1974825050 @default.
- W4235283202 hasRelatedWork W1975614538 @default.
- W4235283202 hasRelatedWork W2013957148 @default.
- W4235283202 hasRelatedWork W2045486336 @default.
- W4235283202 hasRelatedWork W2049800034 @default.
- W4235283202 hasRelatedWork W2064421528 @default.
- W4235283202 hasRelatedWork W2073660835 @default.
- W4235283202 hasRelatedWork W2086118644 @default.
- W4235283202 hasRelatedWork W2613407879 @default.
- W4235283202 hasVolume "19" @default.
- W4235283202 isParatext "false" @default.
- W4235283202 isRetracted "false" @default.
- W4235283202 workType "article" @default.